← All trials
NCT05938075
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 4, 2023
- Primary completion
- Aug 31, 2025
- Completion date
- Aug 31, 2025
- First posted
- Jul 10, 2023
- Last posted
- Nov 21, 2023
- Enrollment
- 130
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Medical Research Council, South AfricaOverall official - principal investigator
- Perinatal HIV Research Unit, BaragwanathOverall official - principal investigator
- Medical Research Council, South AfricaOfficial
- Medical Research Council, South AfricaCollaborator
- Perinatal HIV Research Unit, BaragwanathOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.